Clinical Trials Logo

Burn clinical trials

View clinical trials related to Burn.

Filter by:

NCT ID: NCT00674999 Withdrawn - Burn Clinical Trials

Use of Amnion on Partial Thickness Burns

Amnion
Start date: June 2005
Phase: Phase 2/Phase 3
Study type: Interventional

To determine if Amnion, used on partial thickness burn injuries would provide an improvement in rate of healing, pain control and scarring as compared to standard medical treatments.

NCT ID: NCT00609661 Withdrawn - Wound Healing Clinical Trials

Adult Stem Cell Response to Burn Injury

Start date: February 2008
Phase: N/A
Study type: Observational

This study is designed to determine the response of adult stems cells, also referred to as mesenchymal stem cells (MSCs), to tissue injury resulting from thermal burns. The study will consist of a one time collection of a patient's blood, about one teaspoon, on the third day following the initial burn. MSCs in the blood will then be quantitated and identified using according to unique proteins found on their cell surface using flow cytometry. The results of flow cytometry analysis will then be compared to the patients characteristics (age, sex, race, etc.), their past medical history (hx of diabetes, hypertension, heart disease, etc.) and to the patient outcome (length of hospital stay, mortality, etc.).

NCT ID: NCT00591916 Withdrawn - Burn Clinical Trials

New Treatment for Donor Sites

Donors
Start date: January 2006
Phase: Phase 2/Phase 3
Study type: Interventional

Primary research questions/Purpose of the Research. 1. Determine the short term (epidermal regeneration, reduction of pain, infections and length of stay) and long term (scarring, long term recovery, and cost of treatment) outcomes of Microbial Nanocellulose (NC) and fine mesh gauze impregnated with hyaluronan and thrombin (HT). 2. Determine if donor site treatment with NC and HT is as safe as the use of Scarlet Red ointment dressing. b. Describe the importance of the knowledge that you expect to gain from the research. To find a donor site dressing that has outcomes equal or better than that of scarlet red.

NCT ID: NCT00591604 Withdrawn - Burn Clinical Trials

High-Dose Vitamin D Deficiency in Burn Injury

VitaminD
Start date: February 2007
Phase: Phase 3
Study type: Interventional

High dose Vitamin D (50,000IU) therapy may increase bone mineral density/bone mineral content after large burns.

NCT ID: NCT00591448 Completed - Burn Clinical Trials

Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients

Start date: October 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the use of Virtual Reality (VR) technology during Physical Therapy (PT) and/or Occupational Therapy (OT) for patients with burns. Research questions: Do patients have increased joint Range of Motion (ROM) and reduced pain when using VR during PT compared to PT/OT when VR is not used? Do scores on an imaging ability scale correlate with the effects of VR when used with PT/OT? Do adults and children differ in their ability to engage in the virtual world?

NCT ID: NCT00591162 Terminated - Burn Clinical Trials

Bone Disease in Severely Burned Children

Start date: October 1992
Phase: Phase 2/Phase 3
Study type: Interventional

Bone metabolism is adversely affected by severe burns in children for a period of time.

NCT ID: NCT00585325 Completed - Burn Clinical Trials

Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes

Start date: October 2004
Phase: N/A
Study type: Interventional

Patients will be randomized prospectively to one of two groups. One group will receive 5 mg/kg of 1% lidocaine, and the other will receive .9 normal saline, instilled into their VAC sponge ½ hour prior to VAC dressing change. All patients will complete a pain assessment tool prior to receiving the instilled lidocaine/placebo, immediately after the procedure and 1 hour after the procedure. Pain scores will then be compared between the lidocaine and placebo groups. Risks: Lidocaine toxicity is a potential risk, but 5 mg/kg of 1 % Lidocaine is below toxicity thresholds in an adult.

NCT ID: NCT00539097 Terminated - Burn Clinical Trials

Evaluation Perioperative Nutrition on Donor Site Healing in Patients Undergoing Reconstructive Burn Surg

Start date: June 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators hope to learn if taking a nutrition drink for a short time after surgery for an elective reconstructive burn injury improves donor site healing, muscle mass and scar maturation time (the point at which the redness, height and firmness of the wound has faded, flattened and softened, and no longer changes in appearance).

NCT ID: NCT00426972 Completed - Trauma Clinical Trials

Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

Start date: January 2007
Phase: Phase 3
Study type: Interventional

This trial will assess the effects of Zesteem (estradiol) on the healing of split thickness skin graft donor sites in patients aged 18-85 years.

NCT ID: NCT00363558 Completed - Burn Clinical Trials

Fixation of Skin Grafts in Patients With Burns: Comparison Between Cyanoacrylate Glue and Skin Staples

Start date: January 2002
Phase: N/A
Study type: Observational

Skin graft fixation is essential for the success of its survival. There are several common methods for skin graft fixation including sutures, skin staples and glue. The study objective is to compare between skin graft fixation with staples and glue in burn patients. The study is retrospective. It Includes 44 patients that were hospitalized in the burn unit, Rabin Medical Center, Israel with 2nd and 3rd degree burns, total body surface area 1-50% during 1/2002-5/2003.All patients were operated for debridement and skin grafting. In 29 patients the skin graft was fixated with staples and in 15 with cyanoacrylate glue (histoacryl). The parameters that will be compared are skin graft take, hospitalization length and local infection.